NAMS ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/5/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-0.52
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)3.70M
NewAmsterdam Pharma Company NV ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ NewAmsterdam Pharma Company NV ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ NewAmsterdam Pharma Company NV ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ NewAmsterdam Pharma Company NV ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ NewAmsterdam Pharma Company NV ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
NAMS ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
NAMS FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-1.7232.78%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)22.50M-50.61%
NewAmsterdam Pharma Company NV(NAMS) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | -0.52/-0.49 | 3.70M/1.66M | -6.50% | 122.57% |
| 5/7/2026 | 03/2026 | -0.40/-0.49 | 3.04M/858.33K | 19.13% | 254.18% |
| 2/18/2026 | 12/2025 | -0.62/-0.39 | 32.00K/5.12M | -62.16% | -99.37% |
| 11/5/2025 | 09/2025 | -0.61/-0.40 | 348.00K/5.29M | -52.74% | -93.42% |
| 8/6/2025 | 06/2025 | -0.15/-0.49 | 19.14M/1.60M | 70.21% | 1097.93% |
| 5/8/2025 | 03/2025 | -0.34/-0.49 | 2.98M/1.58M | 30.22% | 89.01% |
| 2/26/2025 | 12/2024 | -0.93/-0.49 | 12.77M/1.76M | -90.75% | 627.33% |
| 11/6/2024 | 09/2024 | -0.18/-0.50 | 29.11M/1.87M | 64.82% | 1454.89% |